Erica Voss
Erica Voss
Janssen Research & Development
Verified email at its.jnj.com
TitleCited byYear
Feasibility and utility of applications of the common data model to multiple, disparate observational health databases
EA Voss, R Makadia, A Matcho, Q Ma, C Knoll, M Schuemie, FJ DeFalco, ...
Journal of the American Medical Informatics Association 22 (3), 553-564, 2015
412015
Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest
RD Boyce, PB Ryan, GN Norén, MJ Schuemie, C Reich, J Duke, ...
Drug safety 37 (8), 557-567, 2014
412014
Exposure to oral fluoroquinolones and the risk of retinal detachment: retrospective analyses of two large healthcare databases
D Fife, V Zhu, E Voss, G Levy-Clarke, P Ryan
Drug safety 37 (3), 171-182, 2014
222014
Accuracy of an automated knowledge base for identifying drug adverse reactions
EA Voss, RD Boyce, PB Ryan, J van der Lei, PR Rijnbeek, MJ Schuemie
Journal of biomedical informatics 66, 72-81, 2017
212017
Switching from risperidone long-acting injectable to paliperidone long-acting injectable or oral antipsychotics: analysis of a Medicaid claims database
EA Voss, PB Ryan, PE Stang, D Hough, L Alphs
International clinical psychopharmacology 30 (3), 151, 2015
172015
The impact of standardizing the definition of visits on the consistency of multi-database observational health research
EA Voss, Q Ma, PB Ryan
BMC medical research methodology 15 (1), 13, 2015
82015
Prevalence of chronic metoclopramide use and associated diagnoses in the US pediatric population
RB Weinstein, D Fife, S Sloan, EA Voss, W Treem
Pediatric Drugs 17 (4), 331-337, 2015
42015
Risk prediction for ischemic stroke and transient ischemic attack in patients without atrial fibrillation: a retrospective cohort study
Z Yuan, EA Voss, FJ DeFalco, G Pan, PB Ryan, D Yannicelli, C Nessel
Journal of Stroke and Cerebrovascular Diseases 26 (8), 1721-1731, 2017
32017
Large-scale adverse effects related to treatment evidence standardization (LAERTES): an open scalable system for linking pharmacovigilance evidence sources with clinical data
Journal of biomedical semantics 8, 1-15, 2017
22017
Liver Test Monitoring: Real-World Compliance for Drugs with Monitoring Requirements at 2-Week Intervals or More Frequently
MA Wilcox, J Hardin, J Weaver, EA Voss
Pharmaceutical Medicine, 1-6, 2019
12019
Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co‐transporter 2 inhibitors versus other antihyperglycemic agents: An observational study of …
L Wang, EA Voss, J Weaver, L Hester, Z Yuan, F DeFalco, MJ Schuemie, ...
Pharmacoepidemiology and drug safety, 2019
2019
Patterns of use of P2Y (12) inhibitors in patients with acute coronary syndrome in routine clinical practice
Z Yuan, J Hardin, EA Voss, LL Hester, J Weaver, K Davis, ES Barnathan
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 28, 143-143, 2019
2019
Existing Evidence in Published Literature for Drug-Condition Pairs
EA Voss, MJ Schuemie, PB Ryan, J van der Lei, PR Rijnbeek
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 26, 563-564, 2017
2017
A NEW TOOL TO AUTOMATE NETWORK META-ANALYSES OF STUDIES EXTRACTED FROM CLINICALTRIALS. GOV
H Karcher, W Wiecek, M Nikodem, E Voss, A Sena, S Cepeda
Value in Health 19 (3), A91, 2016
2016
Study comparing the substitution of injectable risperidone in prolonged action by injectable paliperidone in prolonged action versus a substitution by oral antipsychotics
E Voss, L Alphs, D Hough, PB Ryan, PE Stang
EUROPEAN PSYCHIATRY 29 (8), 658-658, 2014
2014
Étude comparant la subtitution de la rispéridone injectable à action prolongée par la palipéridone injectable à action prolongée versus une substitution par antipsychotiques oraux
E Voss, L Alphs, D Hough, PB Ryan, PE Stang
European Psychiatry 29 (8), 658, 2014
2014
Su1269 Chronic Metoclopramide Use: A Surrogate for Refractory GERD in Children?
R Weinstein, S Sloan, D Fife, E Voss, WR Treem
Gastroenterology 146 (5), S-420-S-421, 2014
2014
The system can't perform the operation now. Try again later.
Articles 1–17